The decreased level of NBAT-1 was associated with the poor prognosis of clear cell renal cell carcinoma (ccRCC) patients, exhibiting the clinical significance of NBAT-1 in the diagnosis and treatment of ccRCC [19]. This evidence concerns the gene NBAT1 and nonpapillary renal cell carcinoma.